Wolverine Trading, LLC Bio N Tech Se Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$78.36 - $124.66 $1.28 Million - $2.03 Million	16,300 Added 25.83%	79,400 $9.43 Million
Q2 2024 Aug 14, 2024	BUY	$80.36 - $102.87 $1.27 Million - $1.63 Million	15,800 Added 33.4%	63,100 $5.07 Million
Q1 2024 May 15, 2024	SELL	$88.96 - $112.35 $427,007 - $539,280	-4,800 Reduced 9.21%	47,300 $4.36 Million
Q4 2023 Feb 14, 2024	BUY	$90.91 - $112.75 $1.25 Million - $1.56 Million	13,800 Added 36.03%	52,100 $5.5 Million
Q3 2023 Nov 15, 2023	SELL	$98.5 - $125.08 $1.4 Million - $1.78 Million	-14,200 Reduced 27.05%	38,300 $4.16 Million
Q2 2023 Aug 23, 2023	BUY	$102.58 - $129.66 $5.39 Million - $6.81 Million	52,500 New	52,500 $5.67 Million
Q4 2022 Feb 14, 2023	SELL	$118.43 - $186.05 $414,505 - $651,175	-3,500 Reduced 6.42%	51,000 $7.66 Million
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $970,140 - $1.39 Million	7,600 Added 16.2%	54,500 $7.28 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $2.99 Million - $4.53 Million	-24,300 Reduced 34.13%	46,900 $6.66 Million
Q1 2022 May 16, 2022	SELL	$126.25 - $231.85 $21.9 Million - $40.2 Million	-173,400 Reduced 70.89%	71,200 $12.4 Million
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $736,576 - $1.23 Million	-3,400 Reduced 1.37%	244,600 $62.8 Million
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $21.5 Million - $46.7 Million	104,500 Added 72.82%	248,000 $68.8 Million
Q2 2021 Aug 06, 2021	BUY	$113.32 - $241.49 $8 Million - $17 Million	70,600 Added 96.84%	143,500 $32.7 Million
Q1 2021 May 14, 2021	BUY	$85.73 - $119.5 $2.1 Million - $2.93 Million	24,500 Added 50.62%	72,900 $7.61 Million
Q4 2020 Feb 12, 2021	BUY	$72.71 - $129.54 $3.52 Million - $6.27 Million	48,400 New	48,400 $4.06 Million

Others Institutions Holding BNTX

# of Institutions

360

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $30B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account